Combination productDrug

Ciliary Neurotrophic Factor clinical trials

Also written NT-501.

studies test it: 17
open now: 1
in phase 3: 3
first study started: 2007

Keep track of what changes. Save the Ciliary Neurotrophic Factor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

NT-501 CNTF Implant: 4
Ciliary neurotrophic factor (CNTF): 2
CNTF implant: 2

Development codes

NT-501: 5

Studies by the year they started

17 studies that test it; most in 2007 (3)

Studies that test Ciliary Neurotrophic Factor, by start year
Year	Studies
2007	3
2011	3
2012	2
2014	1
2016	1
2017	2
2018	1
2021	2
2025	2

By phase

A phase 1/2 study counts in both.

Phase 1: 4
Phase 2: 10
Phase 3: 3
Phase 4: 1

What it is tested for

Each study’s main condition, where its own words name it.

Telangiectasis: 6
Glaucoma: 2
Retinitis: 2
Macular Degeneration: 1
Usher Syndromes: 1
Color Vision Defects: 1
Optic Neuropathy, Ischemic: 1
Glaucoma, Open-Angle: 1

Who runs them

Industry 12 · Other 5

Neurotech Pharmaceuticals (12) · Stanford University (2) · Jeffrey L Goldberg (2) · National Eye Institute (NEI) (1)

Often tested with

Tested in the same studies.

Revakinagene taroretcel (1)

Studies

Open first, then newest update. How each study uses Ciliary Neurotrophic Factor is read from its arms, and is right about nine times in ten.